These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37932565)

  • 21. Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer.
    Elshetry ASF; El-Fawakry RM; Hamed EM; Metwally MI; Zaid NA
    Eur J Radiol; 2022 Jun; 151():110282. PubMed ID: 35381566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer.
    Kimura K; Yoshida S; Tsuchiya J; Kitazume Y; Waseda Y; Tanaka H; Yokoyama M; Toda K; Yoshimura R; Masaya I; Koga F; Tateishi U; Fujii Y
    Eur Radiol; 2023 Sep; 33(9):6245-6255. PubMed ID: 37045982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor.
    Kim SH
    Abdom Radiol (NY); 2020 Feb; 45(2):491-498. PubMed ID: 31422440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of multiparametric MRI based Vesical Imaging-Reporting and Data System (VI-RADS) scoring in discriminating between non-muscle invasive and muscle invasive bladder cancer.
    Islam NU; Jehangir M; Parry AH; Nazir SS; Bilal S
    Pol J Radiol; 2023; 88():e356-e364. PubMed ID: 37701172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
    Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic benefit of multiparametric MRI over contrast-enhanced CT in patients with bladder cancer: A single-center 1-year experience.
    Hagen F; Norz V; Thaiss WM; Mair A; Rausch S; Bedke J; Nikolaou K; Stenzl A; Kruck S; Hepp T; Kaufmann S; Estler A
    Eur J Radiol; 2022 Jan; 146():110059. PubMed ID: 34839167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vesical Imaging-Reporting and Data System (VI-RADS®): Initial experience in the classification of muscle-invasive bladder cancer.
    Etxano J; Rodríguez-Vigil B; Pérez F; Beardo P; Viguri A; Tolosa E; Martínez de Guereñu B
    Actas Urol Esp (Engl Ed); 2021 May; 45(4):320-325. PubMed ID: 33531283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer.
    Necchi A; Basile G; Gibb EA; Raggi D; Calareso G; de Padua TC; Patanè D; Crupi E; Mercinelli C; Cigliola A; Tateo V; Giannatempo P; Moschini M; Briganti A; Montorsi F; Messina A; Ross JS; Pavlick D; De Cobelli F; Brembilla G
    BJU Int; 2024 Feb; 133(2):214-222. PubMed ID: 37803523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer.
    Akcay A; Yagci AB; Celen S; Ozlulerden Y; Turk NS; Ufuk F
    Clin Imaging; 2021 Sep; 77():25-36. PubMed ID: 33639497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: A prospective study.
    El-Karamany TM; Al-Adl AM; Hosny MM; A Eldeep H; El-Hamshary SA
    Urol Oncol; 2022 Oct; 40(10):454.e1-454.e7. PubMed ID: 35466036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting Muscle Invasion of Bladder Cancer Using a Proposed Magnetic Resonance Imaging Strategy.
    Wang X; Tu N; Sun F; Wen Z; Lan X; Lei Y; Cui E; Lin F
    J Magn Reson Imaging; 2021 Oct; 54(4):1212-1221. PubMed ID: 33998725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations.
    Del Giudice F; Flammia RS; Pecoraro M; Moschini M; D'Andrea D; Messina E; Pisciotti LM; De Berardinis E; Sciarra A; Panebianco V
    World J Urol; 2022 Jul; 40(7):1617-1628. PubMed ID: 35294583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VI-RADS in bladder cancer: Overview, pearls and pitfalls.
    Lai AL; Law YM
    Eur J Radiol; 2023 Mar; 160():110666. PubMed ID: 36689790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of actual stage prediction using Vesical Imaging Reporting and Data System (VI-RADS) before radical cystectomy for urothelial carcinoma in SUPER-UC-Cx.
    Kim SH; Han JH; Jeong SH; Yuk HD; Jeong CW; Kwak C; Kim HH; Kim SY; Kim TM; Cho JY; Ku JH
    Transl Androl Urol; 2023 Feb; 12(2):168-175. PubMed ID: 36915877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
    Bicchetti M; Simone G; Giannarini G; Girometti R; Briganti A; Brunocilla E; Cardone G; De Cobelli F; Gaudiano C; Del Giudice F; Flammia S; Leonardo C; Pecoraro M; Schiavina R; Catalano C; Panebianco V
    Radiol Med; 2022 Aug; 127(8):881-890. PubMed ID: 35763251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Vesical Imaging-Reporting and Data System (VI-RADS) scoring system in predicting muscle invasion of bladder cancer.
    Liu S; Xu F; Xu T; Yan Y; Yao X; Tang G
    Transl Androl Urol; 2020 Apr; 9(2):445-451. PubMed ID: 32420150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Ye L; Chen Y; Xu H; Xie H; Yao J; Liu J; Song B
    Eur Radiol; 2022 Sep; 32(9):6480-6492. PubMed ID: 35362750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Gmeiner J; Garstka N; Helbich TH; Shariat SF; Baltzer PA
    Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.